Updated Canadian guidelines for use of combined hormonal contraceptionSome guidance on the use of estrogen–progestin contraceptive methods New Canadian guidelines for managing overactive bladder in adultsProvide evidence-based guidance, supplemented with consensus expert opinion Hepatitis B vaccine: Canadian update Recommendations on booster doses, preferred schedules, use in diabetes patients, and monitoring immunocompromised patients. Updated Canadian guidelines for opioid use in chronic noncancer pain Stress optimization of nonopioids, lower opioid doses and gradual tapering of opioid doses FluMist Quadrivalent intranasal vaccine safe for use in patients with egg allergy 2016/17 Canadian influenza vaccine guidelines revised for intranasal flu vaccine. Revised 2016/17 recommendations for FluMist Quadrivalent intranasal vaccine use in children Evidence does not support preferential use in children and adolescents 2–17 years of age. Updated Canadian guidelines for managing depression Published as six separate articles, the guidelines address various aspects of depression management. 2016 Canadian dyslipidemia guidelines Despite controversy, experts continue to recommend LDL-C targets for patients started on lipid-lowering therapy. Clinical Notes: July/August 2016 Updates on new research findings and clinical guidelines. Updated Canadian diabetes guidelines for pharmacologic management of type 2 diabetes Empagliflozin should be added when glycemic targets are not met in patients with clinical cardiovascular disease. First Previous 8 9 10 11 12 Next Last
